ACTSI Investigator Dr. Mark Mulligan in the News

Mark J. Mulligan, MD, FIDSA 
Dr. Mulligan is an ACTSI investigator, professor in the Division of Infectious Diseases and trained as a molecular virologist with Richard Compans at UAB. He leads a group of collaborating faculty and staff at the Hope Clinic of the Emory Vaccine Center. His research focuses on understanding the mechanisms of successful vaccines and developing needed new or improved vaccines, e.g., HIV, pandemic influenza, tuberculosis and biodefense vaccines. Read more… 

The GA Voice | Get ready to ride for HIV research
November 3, 2011

Georgia Health News | Enlist in the war against HIV
May 18, 2012

Emory News Center | Need for HIV vaccine is greater than ever 
May 18, 2012

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?